The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading ->
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading ->
According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading ->